Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tyra Biosciences is a US-based biotechnology company specializing in the development of precision medicine therapies for cancer. Through its proprietary platform, the company focuses on the targeted inhibition of FGFR mutations to treat solid tumors and advance patient care through targeted innovations.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tyra Biosciences is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tyra Biosciences last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.69 USD.
Across its last 3 earnings reports, Tyra Biosciences stock moved by ±3.4% on average the following day. The largest reaction was +4.9% on 08/06/2026; 3 of 3 reactions were positive.
Tyra Biosciences has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.